期刊文献+

阿立哌唑注射液肌肉刺激、溶血及过敏试验研究 被引量:3

Experimental study of Aripiprazole Injection on muscular irritation, hemolysis and sensitization
原文传递
导出
摘要 目的评价阿立哌唑注射液的肌肉刺激性,观察其否具有溶血、凝聚及过敏反应。方法采用兔股四头肌sc给药,观察阿立哌唑注射液对注射局部肌肉的刺激性;采用2%兔血红细胞混悬液检查阿立哌唑注射液有无溶血和红细胞凝聚反应;采用豚鼠全身主动过敏试验(ASA)评价阿立哌唑注射液有无过敏反应。结果阿立哌唑注射液对兔红细胞无溶血及凝聚作用;新西兰兔单次及连续7 d sc给予阿立哌唑注射液,均发现其对股四头肌有刺激作用,以肌纤维的变性坏死为主,肌纤维崩解消失,病灶内可见散在的炎细胞浸润,停药14 d后刺激反应消失;每只3.75、7.50 mg剂量下给予阿立哌唑注射液,豚鼠未见过敏反应。结论阿立哌唑注射液未见溶血和过敏反应,较高浓度下可能会引起肌肉刺激性反应。 Objective To evaluate the muscular irritation, hemolysis and sensitization of Aripiprazole Injection. Methods Thelocal muscle irritation of Aripiprazole Injection was observed through sc injection on quadriceps femoris in rabbits. The 2% redblood cell suspension in the blood of rabbit was used to check whether Aripiprazole Injection could cause the reaction of emolysisand erythrocyte agglutination. The method of systemic active allergic test (ASA) was used to evaluate the effect of AripiprazoleInjection on allergic reaction in Guinea pigs. Results No evidence of hemolyzation and aggregation on rabbit erythrocyte in vitrowas observed after Aripiprazole Injection treatment. Test substance was sc injected by single or multiple doses for 7 d, both of themhad muscular irritation on New Zealand rabbits, the major pathologic change was the degeneration and necrosis of myofibers,myofibers broke apart and disappeared, lots of inflammatory cells immersed. After drug withdrawal, muscular irritation wasrecovered. No allergic reactions on Guinea pigs in vivo were observed at the low dose of 3.75 mg and the high dose of 7.5 mg.Conclusion Aripiprazole Injection has no hemolyzation and sensitization, but may cause muscle irritation at higher concentration.
出处 《药物评价研究》 CAS 2017年第9期1270-1273,共4页 Drug Evaluation Research
关键词 阿立哌唑注射液 肌肉刺激 溶血性 过敏 Aripiprazole Injection muscular irritation hemolysis sensitization
  • 相关文献

参考文献3

二级参考文献20

  • 1周澎涛,刘蕾.新型静脉用甘氨酰环素类抗菌药替加环素[J].中国新药杂志,2007,16(4):328-332. 被引量:13
  • 2刘春亮,王华.替加环素的研究进展及临床应用[J].安徽医药,2007,11(7):648-650. 被引量:6
  • 3Kilkuchiet T,et al:J Pharmacol Exp Ther.1995;274(1):329—336.
  • 4Semba J,et al:Neuropharmacology,1995;34(7):785—791.
  • 5Fujikawa M,et al:Pharmacol Biochem Behav.1996;53(4):903—909.
  • 6Alison P,et al:Molecular Brain Research,1998;55:285—292.
  • 7Inoue A。et al:Brain Res Mol Brain Res.1998;55:285—292.
  • 8Shapine DA,et al:Neuropsychopharmacology,2003:1 46(5):214—216.
  • 9Bruce S:Drugs Research and Development,1999;2(1):47—48.
  • 10Stephen M,et al:Drugs oI the Future,2000;25(9):961—963.

共引文献384

同被引文献32

引证文献3

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部